Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

GI Pathology 101! For each subsite, we go through path basics – histology, IHC & molecular markers, key features from resection specimen & more. I ask Suntrea Hammer to explain path slides to me like I’m a 5-year-old 😀 Here's Part 1: CRC Full video link & slides below🧵1/4:

13,719 görüntüleme • 1 yıl önce •via X (Twitter)

8 Yorum

Dr. Nina Niu Sanford profil fotoğrafı
Dr. Nina Niu Sanford1 yıl önce

YouTube link 2/4:

Dr. Nina Niu Sanford profil fotoğrafı
Dr. Nina Niu Sanford1 yıl önce

Slides 3/4:

Dr. Nina Niu Sanford profil fotoğrafı
Dr. Nina Niu Sanford1 yıl önce

Mores slides 4/4. Though much more helpful to listen to Suntrea explain the histo: Other subsites coming soon, let me know any feedback.

Raffaele Di Giacomo, PhD profil fotoğrafı
Raffaele Di Giacomo, PhD1 yıl önce

Dr. Sanford, your approach to breaking down GI pathology is highly commendable! Understanding histology, IHC, and molecular markers is crucial for accurate diagnosis and treatment planning. A question for @SuntreaHammer: what do you consider the most challenging aspect when explaining molecular markers to a non-specialist? For anyone interested in deepening their knowledge or seeking more detailed reviews on topics like these, I recommend It’s a one-stop platform answering every biomedical question and generating comprehensive reviews. #Medicine #Gastroenterology

Erman Akkus profil fotoğrafı
Erman Akkus1 yıl önce

❓Adjuvant/perioperative chemotherapy for curative liver metastesectomy of CRC? @myESMO #ESMOGI25 ✅Probably DFS but no OS benefit ✅decision should be individualized ❓ctDNA? 👉 #cancer #oncology #MedX #CRC @OncoAlert @realbowtiedoc

Mario Balsa profil fotoğrafı
Mario Balsa1 yıl önce

🆕 Final analysis of SURF-RCT/SURF-Cohort for small HCC just dropped in @JCO_ASCO: surgery vs RFA ⚔️ 🎯 5-yr OS: 74.6% (S) vs 70.4% (RFA) 🎯 5-yr RFS: 42.9% (S) vs 42.7% (RFA) 💥 AEs: 3.3% (S) vs 0% (RFA) Sometimes, less is more — and the probe wins again ⚖️ Congrats to @YoKawaguchiUT and all the team! 👏🏼 @OncoAlert #OncoAlertAF @_SEOM @GrupoTTD

Neil Iyengar, MD profil fotoğrafı
Neil Iyengar, MD1 yıl önce

I am delighted to join @WinshipAtEmory as co-director of breast oncology and director of cancer survivorship. Excited to join this team with deep and synergistic expertise where we will continue advancing cutting-edge science at the intersection of metabolic health and cancer!

Stephen V Liu, MD profil fotoğrafı
Stephen V Liu, MD1 yıl önce

Make plans for #DCLung25 - Saturday, October 4th - Washington DC - a one-day @IASLC endorsed comprehensive lung cancer conference! Dr. Marina Garassino @marinagarassino joins with the latest updates in immunotherapy for NSCLC. Register today!

Benzer Videolar